Status | Study |
Not yet recruiting |
Study Name: Pilot Study of Paclitaxel Plus Pembrolizumab in Metastatic HER2-Negative Breast Cancer Condition: Breast - Female Male Breast Cancer Date: 2017-01-10 Interventions: Drug: Pembrolizumab IV (in the |
Recruiting |
Study Name: Pre-operative IRX-2 in Early Stage Breast Cancer (ESBC) Condition: Breast Neoplasm Breast Neoplasm, Male Date: 2016-10-28 Interventions: Drug: Cyclophosphamide One dos |
Active, not recruiting |
Study Name: Silent Breast Cancer A Study of the Disease Prevalence Held by Imaging Guided Biopsies in Autopsy Specimens Condition: Female Breast Cancer Male Breast Cancer Date: 2015-06-17 Interventions: Procedure: Bilateral mastectomy |
Active, not recruiting |
Study Name: Sense of Hope Alleviates Fatigue in Breast Cancer Survivors Condition: Carcinoma of Male Breast Date: 2015-01-06 |
Active, not recruiting |
Study Name: FDG PET and DCE-MRI in Predicting Response to Treatment in Patients With Breast Cancer Condition: Male Breast Cancer Stage II Breast Cancer Date: 2013-08-26 Interventions: Radiation: fludeoxyglucose F 18 |
Active, not recruiting |
Study Name: Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Hormone Therapy Condition: Male Breast Cancer Recurrent Breast Cancer Date: 2012-10-31 Interventions: Drug: vorinostat Given PO |
Active, not recruiting |
Study Name: Finasteride (MK-0906) and Male Breast Cancer - A Register-Based Nested Case-Control Study (MK-0906-162/2003.021). Condition: Male Breast Cancer Date: 2012-09-24 |
Recruiting |
Study Name: Tamoxifen +/- GnRH Analogue vs Aromatase Inhibitor + GnRH Analogue in Male Breast Cancer Patients Condition: Male Breast Cancer Date: 2012-07-09 Interventions: Drug: Tamoxifen 25 mg daily. |
Withdrawn |
Study Name: Ex Vivo-Expanded HER2-Specific T Cells and Cyclophosphamide After Vaccine Therapy in Treating Patients With HER2-Positive Stage IV Breast Cancer Condition: HER2-positive Breast Cancer Male Breast Cancer Date: 2010-09-22 Interventions: Biological: HER-2/neu peptide vaccine |
Active, not recruiting |
Study Name: Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Aromatase Inhibitor Therapy Condition: Male Breast Cancer Recurrent Breast Cancer Date: 2010-06-22 Interventions: Drug: vorinostat Given PO |